InsiderSignal.AI

InsiderSignal.ai

MPLT - Maplight Therapeutics, Inc.

Insider Purchase by Novo Holdings A/S (10%)

6 Months
After Trade
Before Trade

Loading data...

Trade Summary

3 months ago, Novo Holdings A/S, serving as 10% owner at Maplight Therapeutics, Inc. (MPLT), purchased 952,941 shares at $17.00 per share, for a total transaction value of $16,199,997.00. Following this transaction, Novo Holdings A/S now holds 3,686,622 shares of MPLT.

This purchase represents a 35.00% increase in Novo Holdings A/S's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, October 28, 2025 and publicly disclosed via SEC Form 4 filing on Thursday, October 30, 2025, 2 days after the trade was made.

Maplight Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Novo Holdings A/S

10%

Novo A/S, also referred to as Novo Holdings A/S, is a Danish investment firm and a major beneficial owner (BO) in various biotechnology companies, including a recent 10% stake in Maplight Therapeutics, Inc. (MPLT) as reported in Form 4 insider trading filings.[[1]](http://www.insiderinsights.com/filer/1388325/novo-a-s)[[6]](https://www.secform4.com/insider-trading/1388325.htm)[[9]](https://www.insiderscreener.com/en/insider/i/45553) As a corporate insider, it has engaged in trading activities related to MPLT, reflecting its strategy of investing in life sciences and healthcare sectors.[[1]](http://www.insiderinsights.com/filer/1388325/novo-a-s)[[9]](https://www.insiderscreener.com/en/insider/i/45553) Novo Holdings A/S originates from the Novo Nordisk Foundation and manages significant assets, focusing on biotechnology, pharmaceuticals, and innovation to support long-term value creation in healthcare.[[3]](https://www.alphaspread.com/security/cse/novo%20b/ownership/block/insider-trading) Its operations involve equity investments, venture capital, and ownership stakes in companies advancing treatments for chronic diseases like diabetes and obesity, leveraging deep roots in Denmark's pharmaceutical heritage through its association with Novo Nordisk A/S.[[3]](https://www.alphaspread.com/security/cse/novo%20b/ownership/block/insider-trading)[[6]](https://www.secform4.com/insider-trading/1388325.htm)

View full insider profile →

Trade Price

$17.00

Quantity

952,941

Total Value

$16,199,997.00

Shares Owned

3,686,622

Trade Date

Tuesday, October 28, 2025

117 days ago

SEC Filing Date

Thursday, October 30, 2025

Filed 2 days after trade

HEALTHCAREBIOTECHNOLOGY

About Maplight Therapeutics, Inc.

Company Overview

No company information available
View news mentioning MPLT

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/991922

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime